Clinical Observation of Xuebijing Injection Combined with Levofloxacin in the Treatment of Urinary Tract Infection
Abstract
OBJECTIVE:To observe the clinical efficacy and safety of Xuebijing injection combined with Levofloxacin for urinary tract infection. METHODS:78 patients with urinary tract infection were randomly divided into control group(38 cases)and treatment group(40 cases). Control group was given Levofloxacin sodium chloride injection 300 mg,bid,intravenously;treatment group was given Xuebijing injection 50 ml added into 0.9% Sodium chloride injection 100 ml,bid,intravenously,within30-40 min on the basis of control group. Treatment course of 2 groups lasted for 7 days. The changes of clinical symptom and signs were observed in 2 groups before and after treatment. The urine routine,hepatic and renal function,blood routine and ADR were observed in 2 groups before and after treatment. RESULTS:Total effective rate of treatment group(82.5%)was significantly higher than control group(63.2%);there was statistical significance(P0.05). The urine routine of both groups were improved significantly;there was statistical significance(P0.05). There was no statistical significance between 2 groups after treatment(P0.05). Clinical symptom and signs of 2 groups were improved significantly;those of treatment group were improved significantly after treatment,compared with control group;there was statistical significance(P0.05). There was no statistical significance in the incidence of ADR between 2 groups(P0.05). No obvions charge was found in hepatic and renal function,blood routine of 2groups during…
Read the paper
Related studies
- Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study
- Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China
- The Role of the NLR and PLR in Urinary Tract Infection
- Threat of Antimicrobial Resistance among Pilgrims with Infectious Diseases during Hajj: Lessons Learnt from COVID-19 Pandemic
- Leclercia adecarboxylata urinary tract infection in a patient with bladder cancer and recurrent hematuria
- A Case Series of Staphylococcus lugdunensis Infection in Cancer Patients at an Academic Cancer Institute in the United States
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.